HIV感染者脑膜炎球菌结合疫苗使用建议——免疫实践咨询委员会,2016年
2016年6月,免疫实践咨询委员会(ACIP)推荐≥2月龄HIV感染者常规使用脑膜炎球菌结合疫苗(A、C、W、Y群,包括MenACWY-D或MenACWY-CRM)。本报告汇总ACIP考虑的证据并提供该人群接种建议与指导。
要点
- ACIP推荐≥2月龄HIV感染者常规接种脑膜炎球菌结合疫苗(A、C、W、Y群)。
- 推荐疫苗包括MenACWY-D(Menactra)或MenACWY-CRM(Menveo)。
- HIV感染者中多数脑膜炎球菌病由A、C、W、Y四群引起。
核心结论
- ACIP推荐≥2月龄HIV感染者常规使用脑膜炎球菌结合疫苗(A、C、W、Y群)。
研究设计与样本
- 本报告为ACIP于2016年6月会议后发布的建议文件,汇总其推荐HIV感染者接种脑膜炎球菌结合疫苗所考虑的证据。
主要发现
- HIV感染者中多数脑膜炎球菌病由A、C、W、Y四个血清群引起。
关键数值与推荐
- 推荐对≥2月龄HIV感染者常规使用脑膜炎球菌结合疫苗(A、C、W、Y群),包括MenACWY-D(Menactra,赛诺菲巴斯德)或MenACWY-CRM(Menveo,葛兰素史克)。
临床怎么用
- 对≥2月龄HIV感染者常规接种脑膜炎球菌结合疫苗(A、C、W、Y群),可选用MenACWY-D或MenACWY-CRM。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
At its June 2016 meeting, the Advisory Committee on Immunization Practices (ACIP) recommended routine use of meningococcal conjugate vaccine (serogroups A, C, W, and Y; including MenACWY-D [Menactra, Sanofi Pasteur] or MenACWY-CRM [Menveo, GlaxoSmithKline]) for persons aged ≥2 months with human immunodeficiency virus (HIV) infection. ACIP has previously recommended routine vaccination of persons aged ≥2 months who have certain medical conditions that increase risk for meningococcal disease (1), including persons who have persistent (e.g., genetic) deficiencies in the complement pathway (e.g., C3, properdin, Factor D, Factor H, or C5-C9); persons receiving eculizumab (Soliris, Alexion Pharmaceuticals) for treatment of atypical hemolytic uremic syndrome or paroxysmal nocturnal hemoglobinuria (because the drug binds C5 and inhibits the terminal complement pathway); and persons with functional or anatomic asplenia (including persons with sickle cell disease). Routine vaccination with meningococcal conjugate vaccine is also recommended for all healthy adolescents in the United States (1). This report summarizes the evidence considered by ACIP in recommending vaccination for HIV-infected persons, and provides recommendations and guidance for use of meningococcal conjugate vaccines (serogroups A, C, W, and Y) among HIV-infected persons aged ≥2 months; the majority of meningococcal disease among HIV-infected persons is caused by these four serogroups.
引用
- MacNeil JR, Rubin LG, Patton M, et al. Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons - Advisory Committee on Immunization Practices, 2016. MMWR Morb Mortal Wkly Rep. 2016. PMID: 27811836. doi:10.15585/mmwr.mm6543a3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。